Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III open-label study of KRP-AM1977Y for respiratory tract infection
jRCT2080223247Phase 3Completed
- Sponsor
- Kyorin Pharmaceutical
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lascufloxacin in Airways Infection, Chronic Respiratory Disease (CRD), aspiration pneumonia and 1 more, sponsored by Kyorin Pharmaceutical. Started Jun 2016; status: completed.
02
Drugs
lascufloxacin
03
Conditions
Airways InfectionChronic Respiratory Disease (CRD)aspiration pneumonialung abscess
Beyond the preview
Go deeper on jRCT2080223247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223247.